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Introduction
Among the many oxygenation reactions catalyzed by 
cytochrome P450-dependent monooxygenases (CYP), epox-
ygenation is a particularly important one (Guengerich 2003; 
Spector 2009). The resulting epoxides vary substantially in 
their stability/reactivity. While some epoxides, such as the 
8,9-exo-epoxide of Aflatoxin  B1, are highly electrophilically 
reactive and represent a major threat, due to their reactivity 
with DNA and proteins, other epoxides are very stable and 
poorly reactive (Guengerich 2003). This allows the body 
to use compounds of the latter type, for instance the ara-
chidonic acid-derived epoxyeicosatrienoic acids (EETs), as 
signaling molecules (Spector 2009). Both, the DNA-reactive 
as well as the signaling epoxides can be readily hydrolyzed 
by epoxide hydrolases (EH), which results in a substantial 
modification of their biologic activity (Marowsky et al. 
2010).
The two major mammalian EHs, the soluble (sEH) and 
the microsomal epoxide hydrolase (mEH), differ in their sub-
cellular localization; sEH is mainly a cytoplasmic enzyme 
with a moderate fraction localized in peroxisomes of certain 
cell types (Enayetallah et al. 2006). In contrast, mEH, like 
the majority of CYPs, is an endoplasmic reticulum (ER)-
resident protein. With respect to their membrane topology, 
CYP and mEH are type-I proteins (Black 1992; Friedberg 
et al. 1996). Their short N-termini that precede their single 
transmembrane helix face the ER lumen while their catalytic 
domains are sitting on the cytoplasmatic surface of the ER. 
CYP is invariably associated with cytochrome P450 reduc-
tase (CPR), the mandatory electron donor for the first step in 
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the CYP catalytic cycle (Lu et al. 1969). However, whether 
CYP and mEH, when expressed within the same cell, also 
form a complex (Fig. 1) to facilitate the production of the 
final metabolites, thus reducing the accumulation of epoxide 
intermediates, is still a matter of debate.
Such complex formation has already been postulated 
some decades ago (Oesch and Daly 1972) and several dif-
ferent attempts have been undertaken to prove its existence 
(Etter et al. 1991; Fujiwara and Itoh 2014; Guengerich and 
Davidson 1982; Oesch and Daly 1972; Taura Ki et al. 2002; 
Taura et al. 2000). However, methodologic limitations of 
the strategies applied to the problem still leave some doubt 
with respect to the validity of the resulting findings, as will 
be explained in the Discussion below.
In the current study, we have developed a FRET-based 
approach to demonstrate close proximity of ER-residing 
type I membrane proteins, including CYP and mEH, which 
we call FAMPIR, for FRET analysis of membrane protein 
interactions in the endoplasmic reticulum. To overcome the 
sensitivity problems associated with the limited expression 
yields of ER-resident proteins, we used FACS analysis of the 
FRET signal to obtain statistically robust results. As a first 
potentially relevant member of the CYP family that might 
interact with mEH we chose CYP2J5, because (i) it is coex-
pressed with mEH in specific CNS cell populations, namely 
the principal neurons of the hippocampus (Fig. 2), and (ii) it 
produces 11,12-epoxyeicosatrienoic acid (Ma et al. 1999), 
a lipid signaling molecule efficiently hydrolyzed by mEH 
(Marowsky et al. 2009).
Due to the essentially non-invasive nature of FAMPIR, 
we were able to unequivocally demonstrate the direct inter-
action of CYP2J5 and mEH in recombinant HEK 293 cells. 
Furthermore, we present with FAMPIR a fast and robust 
method that is generally applicable to the interaction analy-
sis of type-I ER-resident proteins.
Methods
Vector construction
A detailed description and graphical representation (Fig. S1) 
of the expression vector construction is given in the Sup-
plementary Information.
Transfection of HEK293 cells
HEK293 were cultivated in DMEM medium  (Gibco®, 
Thermo Scientific, Waltham, MA, USA) supplemented with 
5% FCS and 2 mM l-glutamine at 37 °C under 5%  CO2. 
When reaching 80% confluency they were split using 0.25% 
Trypsin/EDTA  (Gibco®, Thermo Scientific, Waltham, MA, 
USA) for the detachment of the cells. Cells were seeded on 
sterile, nitric acid-treated glass coverslips placed in 12 well 
(18 mm) dishes for subsequent microscopic analyses, or in 
CPR mEH CYP 
CPR mEH CYP 
A 
B 
Fig. 1  Different options for the association behavior of CYP and 
mEH in the endoplasmic reticulum: a CYP and mEH remain essen-
tially unassociated, or b CYP and mEH form a complex. The asso-
ciation of CYP and CPR is well established and thus can be used 
as a positive control. mEH microsomal epoxide hydrolase, CPR 
cytochrome P450 reductase, CYP cytochtome P450-dependant 
monooxygenase
CYP2J5 mEH 
Nissl 
ISH 
EI 
CA1 
CA3 
DG 
CA1 
CA3 
DG 
Fig. 2  CYP2J5 and mEH expression in the adult mouse hippocam-
pus. In  situ hybridization analysis of CYP2J5 and mEH mRNA 
expression (middle row), compared with (upper row) and normalized 
to (lower row) a general nucleic acid staining in the adult mouse hip-
pocampus. Pictures represent sagittal sections taken from the Allen 
brain atlas (link: http://mouse.brain-map.org), specifically experi-
ments 513,229 (CYP2J5) and 68,498,247 (mEH) (Lein et al. 2007). 
Note that the expression levels for both mRNAs are highest in the 
CA3 region of the hippocampus and indicate strong expression in 
the principal neurons of this region. CA1 cornu ammonis area 1, CA3 
cornu ammonis area 3, DG dentate gyrus, EI expression index (ISH 
signal intensity normalized to Nissl staining); ISH in situ hybridiza-
tion with specific antisense probes, Nissl Nissl staining for nucleic 
acids
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6 cm dishes for subsequent FACS analyses. Transient trans-
fection was carried out using Jet-PEI™ reagent (Polyplus-
Transfection, USA), following the manufacturers protocol.
FRET analyses by confocal microscopy were performed 
on an LSM710 confocal microscope (Carl Zeiss AG, 
Oberkochen, Germany) equipped with an EC Plan-Neo-
fluar 40×/1.30 Oil DIC M27 objective. The CFP channel 
was excited with the 458 nm laser line and emission was 
recorded at 470–485 nm. The YFP channel used the 514 nm 
laser line and emission was recorded at 521–540 nm. Forty-
eight hours after transfection, cells on coverslips express-
ing the fluorescent chimeras were washed once with PBS, 
mounted in a live imaging chamber and covered with 1 ml 
HEPES-based imaging medium (1× Live Cell Imaging 
Solution, Molecular Probes, USA). Cells were analyzed 
at 37 °C for a maximum of 45 min. After CFP and YFP 
colocalization was assessed, images were taken using the 
multichannel acquisition mode. For the analysis of acceptor 
photobleaching, images were first taken from an appropriate 
field of cells in the CFP and YFP channels. Then, YFP pho-
tobleaching was applied with 50 iterations for 0.3 ms using 
the 514 nm laser at 100% intensity. Thereafter, images were 
taken again. The degree of FRET was calculated using the 
Image J analysis software by estimating the degree of CFP 
dequenching due to the destruction of the YFP in a given 
region of interest.
FRET analysis by FACS
This procedure was adapted from Banning et al. (2010), 
Thyrock et  al. (2010), with some minor modifications. 
Forty-eight hours after transfection, cells were trypsinized 
and resuspended in 500 µl of DMEM without phenol red, 
containing 5% FCS. Cell density was approximately 2 × 106 
cells/ml. FRET analyses were carried out on an LSR II 
Fortessa (BD Biosciences, Franklin Lakes, NJ, USA), 
using the sensitized emission method with the following 
filter settings: YFP channel (488 nm, 530/30 filter, 505 LP), 
CFP channel (405 nm, 450/50 filter) and the FRET channel 
(405 nm 525/50 filter, 505 LP). During analysis, samples 
were first gated according to forward scatter (FSC) and side 
scatter (SSC) characteristics to ensure that only single cells 
were analyzed. A total of 5 × 104 cells per sample meeting 
these criteria were included. Using cells expressing only 
CFP or YFP chimeras, background or false FRET signals 
due to bleed-through were efficiently corrected for with 
the built-in compensation procedure provided by the BD 
FACSDiva™ software. The subpopulation displaying sig-
nificant YFP and CFP expression was selected and analyzed 
for FRET in a CFP vs FRET plot. For each session of record-
ings, the selection gate P2 defining the FRET-positive events 
was individually adjusted, based on the respective measure-
ments obtained with cells expressing only either CFP or YFP 
chimera to compensate for potential day-to-day variations in 
any step of the analytical procedure.
Proximity ligation assay (PLA)
For the isolation of primary hippocampal neurons, hip-
pocampi were dissected from the brains of newborn 
C57Bl6/J mice (P0-2), cut into small pieces, rinsed with ice 
cold PBG [glucose, 10 mM, and BSA, 1 mg/ml, in phos-
phate buffered saline (PBS)], and subsequently digested in 
PBG containing 0.5 mg papain and 1 mg DNAse per ml 
at 37 °C in a volume of 2.5 ml per animal. After 10 min, 
the supernatant was aspirated and the remaining tissue was 
washed twice with DMEM. Finally, cells were dissociated in 
1.5 ml DMEM containing 10% FCS and 2 mM l-glutamine 
using a fire-polished Pasteur pipette. This suspension was 
seeded on polylysine-precoated coverslips and subsequently 
incubated in 2 ml mouse hippocampal medium [MEM/B27/
glucose  (Gibco®, Themo Scientific Fischer, MA, USA)]. 
After 48 h, 20 µl of a solution of 3.5 mg uridine and 1.5 mg 
5-fluoro desoxyuridine per ml were added to stop the divi-
sion of glial cells.
After additional 14–16 days in culture, cells were briefly 
washed with PBS and fixed in methanol at −20 °C for 
15 min, followed by three 10-min washing steps in buffer 
A (Olink Bioscience, Sweden). Permeabilization solution 
[0.1% triton-X100 and 10% normal donkey Serum (NDS) 
in buffer A], was applied to the cells for 5 min, followed 
by 3 washes in PBS. The primary antibodies, rabbit anti-
CYP2J2 (Ma et al. 1999; kind gift from Darryl Zeldin) 
and goat anti-rat mEH (MEH1, Detroit R&D, USA) were 
diluted 1:200 in PBS containing 10% NDS, and incubated 
overnight at 4 °C in a humid chamber. On the next morn-
ing, coverslips were washed 3 times for 10 min in buffer A. 
Subsequent incubations were done in a humid chamber at 
37 °C, using the Duolink in situ PLA probes and detection 
reagents FarRed (Olink Bioscience, Sweden). Briefly, 40 µl 
of the Duolink PLA probes solution (rabbit PLUS and goat 
MINUS), was placed on the coverslips and incubated for 
1 h. After 2 washes of 5 min with buffer A, samples were 
incubated with the ligation solution for 1 h, followed by 2 
washes of 2 min with buffer A. Samples were incubated 
for 2 h with the amplification solution containing detection 
reagent FarRed. Two final washes of 10 min were done with 
1× buffer B and one wash of 1 min in 0.01× buffer B. Liq-
uid was thoroughly tapped off the coverslips and mounted 
with ProLong Gold Antifade Reagent plus DAPI reagent 
(Molecular Probes, USA). Images were taken within 24 h.
Statistical evaluation
Statistical analyses were performed using the software pack-
age Prism 5 for Mac OS X (www.graphpad.com). Samples 
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to be analyzed were first subjected to a 1-way ANOVA, fol-
lowed by a Dunnett’s test for the comparison of multiple data 
sets with a single control (Dunnett 1955).
Results
Construction and validation of expression vectors
YFP and CFP were chosen as the FRET pair to be N-ter-
minally fused to the proteins of interest. To force their ER 
intraluminal localization, they were both equipped with an 
N-terminal leader peptide derived from the human ApoE 
protein. The ORFs for CYP and mEH were subsequently 
inserted in frame behind the YFP and the CFP ORF, 
respectively.
To ensure constant ratios of the two interaction partners 
we decided to construct bicistronic expression vectors to 
obtain both interaction partners from a single transcript. In 
a first series of experiments, we used the internal ribosomal 
entry side (IRES) of eIF4G that we successfully employed 
for similar purposes in previous work (unpublished) to initi-
ate the synthesis of the second fusion protein coded on the 
above single transcript. However, transfection of HEK293 
cells with such constructs reproducibly resulted in the 
expression of a single, unexpectedly large fusion protein that 
did not match in size with the proteins obtained when only 
YFP–CYP or CFP–mEH alone were expressed in HEK293T 
cells. Resequencing of the complete constructs verified the 
correctness of their sequences and the nature of the observed 
artifacts remained obscure. We, therefore, decided to replace 
the stop codon of the first encoded fusion protein and the 
IRES with a viral P2A peptide, that leads to a discontinu-
ous polypeptide synthesis on translation, thus affording two 
separate proteins in stoichiometric quantities (Szymczak 
et al. 2004). The lack of appropriate restriction sites for the 
direct modification of our complex expression construct was 
easily overcome using the Gibson cloning protocol (Gibson 
et al. 2009) as described in the Supplementary Information. 
Transfection of HEK293 cells with the resulting expression 
vector (Fig. 3a) finally resulted in the expression of the two 
desired fusion proteins in a 1:1 ratio, as evidenced by immu-
noblotting using a GFP antibody for the detection of the 
recombinant proteins (Fig. 3b).
In the final construct, the ORFs of CYP and mEH were 
flanked by unique restriction sites that allowed the exchange 
of these ORFs against other sequences of interest (Fig. 3a). 
As a functional positive control for our interaction analy-
sis, we exchanged the mEH ORF against that of the mouse 
CPR for which a physical interaction with CYP is essential 
for the catalytic activity of the latter. As a respective nega-
tive control, we chose to fuse the CFP to just a membrane 
anchor without a cytoplasmic protein domain being attached. 
We inserted the first and second helix of the rat GABA B2 
receptor (Kaupmann et al. 1998; Zemoura et al. 2013) at the 
C-terminus of CFP, based on the reported topology of these 
helices. The second transmembrane helix was equipped with 
a C-terminal KDEL signal to ensure retention of the fusion 
protein in the ER (Tang et al. 1992).
FRET analyses by confocal microscopy
Co-localization of fusion proteins in the ER of transfected 
cells was verified by confocal microscopy using the endo-
plasmic reticulum-specific dye ER-ID® Red (Enzo Life Sci-
ences, Inc.). All fusion proteins displayed the expected co-
localization with the ER marker, as well as with each other 
in the case of the co-expressions of two fluorescent fusion 
proteins.
We next tried to assess the physical association of our 
fusion protein pairs by FRET analyses. Using a construct 
that allowed the cytoplasmic expression of a soluble YFP/
CFP fusion protein as a technical control we established the 
most suitable detection procedure for our microscopy-based 
FRET analyses. Among a variety of different protocols, 
including sensitized emission and different photobleaching 
Fig. 3  Experimental strategy for FAMPIR. a Design of the expres-
sion vector. The essential core element is an open reading frame that 
allows the simultaneous production of two transmembrane proteins 
from a single start codon, mediated by a P2A peptide sequence (gray 
box). The skipped peptide bond is indicated by a black arrow. Signal 
peptides derived from the human ApoE gene (dark blue boxes marked 
by “P”) direct the N-termini of the mature recombinant proteins into 
the ER lumen and are cleaved off during translation (cleavage sites 
are indicated by red arrows). Thus, the two FRET partners YFP (yel-
low box) and CFP (cyan box) are translocated into the lumen of the 
ER during protein synthesis. Their coding sequences are followed in 
frame by the native ORFs of the two type I transmembrane proteins 
(red and green boxes) to be analyzed for their interaction. Their native 
N-terminal signal sequences remain uncleaved and act as stop transfer 
signals during translation, thus resulting in a cytoplasmic orientation 
of the resulting proteins. The transcription of the single RNA coding 
for all these elements is under the control of the strong cytomegalovi-
rus promoter (CMV; light blue box). Note that the coding sequences 
for the type I membrane proteins to be analyzed by FAMPIR can be 
conveniently exchanged using the indicated unique restriction sites. b 
Expression products resulting after transfection of cells. The resulting 
membrane topology of proteins expressed from the above construct 
is shown on the left. On the right, an immunoblot analysis of cell 
lysates obtained after transfection with two different constructs are 
shown. Lane 1: CYP2J5 (A) and mouse mEH  (B1); lane 2: CYP2J5 
(A) and mouse CYP reductase  (B2). An anti-GFP antibody was 
used for immunostaining. c FACS-FRET analysis. Results of FACS-
FRET analyses are displayed as diagrams with FRET intensity plot-
ted against CFP fluorescence intensity. The protein topology of the 
analyzed samples is shown above each diagram. All diagrams are 
based on authentic data derived from the following samples: Nega-
tive control—coexpression of YFP–CYP2J5 with CFP-membrane 
anchor only; test sample—coexpression of YFP–CYP2J5 with CFP–
mEH; functional positive control—fusion protein of YFP and CFP 
expressed in the cell cytoplasm
◂
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strategies, acceptor photobleaching gave the most sensi-
tive and consistent results. However, none of our test con-
structs, including the CYP/CPR pair positive interaction 
control, gave a statistically significant FRET signal (Fig. 
S2). Because the expression yield obtained for the cytoplas-
matic positive control was much higher compared to that 
of our ER-localized fusion proteins, we concluded that the 
microscopic FRET analysis—at least in our hands—was not 
sufficiently sensitive to pick up our apparently quite weak 
signals.
FACS‑based FRET analysis of membrane protein 
interaction in the endoplasmic reticulum (FAMPIR)
To efficiently preselect for cells with sufficient fluorophore 
expression levels and to increase the statistical power of our 
YFP CFP 
mEH CYP 
YFP 
CYP 
CFP YFP CFP 
CPR CYP 
CFP 
mEH 
YFP 
CYP 
in
te
ns
ity
 C
FP
 [r
fu
] 
negative 
control 
biological 
positive 
control 
test 
sample 
CFP 
only 
YFP 
only 
non- 
transfected 
intensity FRET [rfu] 
0% 0% 0% 0.1% 14% 16% 
intensity YFP [rfu] 
0.2% 0.3% 0.3% 16% 25% 13% 
0
5
10
15
20
25
*** ***
%
 F
R
ET
-p
os
iti
ve
 c
el
ls
in
te
ns
ity
 C
FP
 [r
fu
] 
A 
B 
C 
D 
negative 
control 
CYP-CPR 
positive control 
CYP-mEH 
test sample 
CFP 
only 
YFP 
only 
non- 
transfected 
3567Arch Toxicol (2017) 91:3561–3570 
1 3
analyses, we switched to a FACS-based FRET approach as 
recently published by Banning et al. (2010) and by Thyrock 
et al. (2010). Using this procedure, we could easily detect 
robust and reproducible FRET signals with both our CYP/
CPR functional positive control as well as our test construct 
for the CYP/mEH interaction (Fig. 4). In contrast, our CYP/
membrane_anchor_only negative control did not display any 
appreciable FRETing. About 10% of the cells selected for 
sufficient YFP and CFP expression, based on their respective 
fluorescence intensities, were identified as FRET positive in 
our test system. This percentage of cells giving a positive 
FRET signal did not significantly differ between the func-
tional control and the test construct, indicating that mEH and 
CYP2J5 appeared to have a very similar degree of physical 
interaction as have CYP2J5 and CPR.
Confirmation of the FAMPIR results with proximity 
ligation assay
To prove CYP2J5/mEH interaction with a second, inde-
pendent method that could be used ex vivo without recom-
binant expression of arguably artificial fusion proteins, we 
employed proximity ligation assay (PLA) analyses in pri-
mary cultures from hippocampal neurons obtained from WT 
and mEH−/− origin. In WT neuronal cultures, a substantial 
fraction of the cells gave a positive PLA signal while this 
was essentially absent in similarly treated mEH−/− cells 
(Fig. 5). These results were in excellent agreement with 
our previous findings in recombinant HEK293 cells using 
FAMPIR, thereby substantiating both, the physical interac-
tion between CYP2J5 and mEH as well as the validity of the 
new experimental procedure.
Discussion
Unequivocal evidence for the specific association of mem-
brane proteins is difficult to provide. From a theoretical con-
sideration, at least a transient physical interaction between 
CYP and CPR appears essential, in view of the electron 
transport from CPR to CYP that initiates catalysis (Lu et al. 
1969). Consequently, first models for this physical interac-
tion have been developed very early (Peterson et al. 1976) 
and a plethora of studies, nicely reviewed by Kandel and 
Lampe (2014), have followed, including X-ray studies that 
give a detailed picture of plausible modes of interaction 
between CPR and CYP (Hamdane et al. 2009).
In contrast, the interaction of mEH and CYP is not essen-
tial for catalysis, yet an attractive possibility, in view of the 
potentially better control of reactive epoxide intermediates 
formed by CYP. Thus, the hypothesis of such an interaction 
has been proposed already in the early seventies by Oesch 
and Daly (1972). Several studies have tried to provide exper-
imental evidence for this interaction, including analyses of 
enzyme kinetics (Guengerich and Davidson 1982; Oesch and 
Daly 1972; Taura Ki et al. 2002), affinity purification (Taura 
et al. 2000), cross-linking (Guengerich and Davidson 1982), 
and/or immunoprecipitation/immobilization (Etter et al. 
1991; Fujiwara and Itoh 2014) approaches. Unfortunately, 
each of these approaches suffers from intrinsic limitations, 
leaving room for alternative explanations other than spe-
cific CYP–mEH interaction as the reason for the observed 
results. For instance, the early kinetic analyses were inter-
preted in the absence of (a) the understanding of peculi-
arities of the two step enzymatic mechanism of mEH that 
is meanwhile well described (Arand et al. 1999; Laughlin 
et al. 1998; Tzeng et al. 1998) and (b) the consideration of 
additional epoxide hydrolase isoenzymes that were identi-
fied later (Decker et al. 2012; Hammock et al. 1976). Affin-
ity purification, immunoprecipitation and plasmon surface 
resonance-based procedures with purified membrane pro-
teins share the intrinsic problem of unspecific hydropho-
bic interactions, due to the presence of the surface-exposed 
hydrophobic membrane anchors of these proteins. Finally, 
the crosslinking studies were unfortunately not performed 
with photoreactive reagents, leaving the possibility of sto-
chastic collision events, rather than specific associations, as 
the basis for the observed cross-linking.
Thus, there was still the need for the unequivocal assess-
ment of mEH–CYP interaction and a non-invasive detec-
tion technology seemed the most suitable for such analyses. 
Fig. 4  Analysis of complex formation between CYP2J5 and mouse 
mEH using FAMPIR. HEK 293T cells were separately transfected 
with 5 different constructs based on the vector represented in Fig. 3a. 
a Represents the set of recombinant proteins expressed in the respec-
tive sample. A non-transfected control was carried along as well. b 
Shows the fluorescence intensity obtained for YFP plotted against 
the fluorescence intensity for CFP. The horizontal and vertical line 
dividing the schemes into quadrants represent the thresholds finally 
defined for CFP (horizontal line) and YFP (vertical line) signal detec-
tion, based on the measurements obtained with the YFP only and the 
CFP only transfectants. Therefore, the upper right quadrant contains 
the fraction of cells that show detectable co-expression of the two 
fluorophores. The figures in the quadrants indicate the percentage of 
CFP/YFP-positive cells as the percentage of the whole cell popula-
tion. The cells from the upper right quadrant were further analyzed 
for FRETing by plotting the FRET signal against the CFP fluores-
cence (c). The rectangular box inside of each panel indicates the 
region where cells were counted as FRET positive. The figure inside 
the box indicates the percentage of FRET positive cells on the basis 
of all CFP/YFP-positive cells. Due to the lack of CFP, YFP or both 
fluorophores, only very few cells of the three control samples on the 
left were included in this analysis. d Shows the cumulative results of 
analyses for all constructs from separate experiments (13–21 inde-
pendent experiments per construct). The values obtained for the 
CYP2J5/CPR construct (biologic positive control) and the CYP2J5/
mEH construct were compared with the CYP2J5/membrane_anchor_
only construct (negative control) by a 1-way ANOVA, followed by a 
Dunnett’s multiple comparison test (Dunnett 1955). ***p < 0.001
◂
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We, therefore, developed the present FRET-based FAMPIR 
approach.
FRET can occur between YFP and CFP, our chosen pair 
of fluorophores, if the distance between the two is below 
10 nm, which is close to the approximate diameter of CYP 
or mEH (approx. 7 nm). We reasoned that attaching the 
FRET partners YFP and CFP to the short intra-ER-lumi-
nal N-termini of CYP and mEH would most likely result 
in a permissive distance (or the least steric hindrance) for 
FRET interactions if the catalytic subunits of mEH and 
CYP would associate on the other side of the membrane. To 
ensure the ER luminal localization of YFP and CFP, their 
coding regions were inserted downstream and in frame 
of a sequence coding for the human ApoE signal peptide. 
The C-terminus of the fluorescent proteins was fused to 
the N-termini of the membrane proteins to be tested in the 
interaction analysis, thus providing their native membrane 
topology. Use of the P2A peptide (Szymczak et al. 2004) to 
fuse the reading frames of the two FRET partners resulted 
in the synthesis of both fusion proteins in an approximately 
1:1 ratio (Fig. 3b), favorable for a sensitive FRET analysis. 
As a “native” positive control, based on the reasoning pro-
vided above, we used CYP2J5 and CPR fusion proteins as 
FRET pair. As a negative control, we combined the CYP2J5 
fusion protein with an artificial construct composed of a 
CFP fusion to the two N-terminal transmembrane helices 
of the GABA B2 receptor, followed by a KDEL sequence. 
Although KDEL was originally described as an ER reten-
tion signal for soluble ER intraluminal proteins, its efficacy 
to retain integral plasma membrane proteins in the ER has 
been experimentally demonstrated by different groups (Bai-
ley et al. 2013; Tang et al. 1992).
Transfection of the respective constructs provided detect-
able ER-resident expression of the respective fluorescent 
fusion proteins. However, attempts to microscopically detect 
FRETting, even with the CYP/CPR positive control, were 
unsuccessful. We therefore included a direct fusion of YFP 
and CFP, expressed soluble in the cytoplasm of transfected 
cell, as a functional positive control to assess our methodo-
logic capability to detect FRET, in principle (Fig. 3c, Fig. 
S2). This construct resulted in reproducible detection of 
FRETting using acceptor photobleaching, the most sensi-
tive of the different methods we employed for microscopic 
FRET analyses. An obvious difference between this positive 
control and our test samples was the expression yield of fluo-
rescent proteins that differed by about an order of magnitude, 
in favor of the soluble fusion protein. We reasoned that, in 
combination with a potentially higher FRET efficiency of 
this fusion protein compared to our test pair, it might be the 
sensitivity of the recording system that precludes the iden-
tification of a positive FRET signal. We, therefore, switched 
to the recently published FACS-FRET analysis (Banning 
et al. 2010; Thyrock et al. 2010), as described above, and 
indeed obtained statistically significant results indicating 
the interrogated association between CYP2J5 and mEH 
(Fig. 4d). The fact that only a small fraction of the cells 
in the analyses using either CYP/mEH or CYP/CPR (only 
around 5–20% FRET-positives in the already preselected 
subpopulation with sufficient YFP and CFP expression) gave 
a positive signal is very well in line with our failure to detect 
this FRET signal by microscopic analysis, where only a lim-
ited number of cells can be analyzed per session. This obvi-
ous sensitivity issue can be nicely overcome by the strength 
of the FACS analysis, i.e., the rapid scanning of many thou-
sand cells in a short period of time. It is striking to see that 
the CYP/mEH test pair behaves very similar to the CYP/
CPR positive control, suggesting a qualitatively and quan-
titatively quite similar mode of association of CYP2J5 with 
these two partners. The PLA assay, which used an in situ 
approach to assess the mEH–CYP interaction using primary 
cultures of hippocampal neurons, further corroborated the 
FACS–FRET findings and, on top, provided evidence for 
the physical association of native CYP2J and mEH in non-
transgenic cells.
In conclusion, our present results clearly demonstrate 
the physical association between CYP2J5 and mouse mEH. 
Future analyses will show how far this interaction with mEH 
extends to other CYP isoforms, in particular those that are 
involved in the formation of reactive epoxide intermedi-
ates from xenobiotics, to allow the immediate processing 
DAPI PLA signal composite 
WT 
KO 
Fig. 5  PLA analysis of the physical association of CYP2J5 and 
mEH in cultivated mouse hippocampal neurons. Neurons from WT 
and mEH−/− mouse hippocampi were isolated, cultivated and sub-
jected to PLA analysis as described in “Methods”. The left column 
shows cell nuclei stained with DAPI, the middle column displays the 
PLA signal (red staining in case of close proximity of the two anti-
gens tested for physical association) and the right column shows the 
superimposed pictures. The upper row gives the results for wild type 
neurons and the lower row that for mEH−/− neurons used as negative 
control. Additional negative controls with WT neurons where either 
the CYP primary antiserum or the mEH primary antiserum were also 
carried out but are not shown
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of these otherwise potentially carcinogenic metabolites. 
CYP2J5 itself has been characterized as an arachidonic 
acid epoxygenase (Ma et al. 1999). The colocalization of 
CYP2J5 and mEH in mouse hippocampal neurons (Figs. 2, 
5), together with our previous finding that mEH contributes 
to the cerebral turnover of arachidonic acid epoxides (EETs; 
Marowsky et al. 2009), suggests an important role of mEH 
in the regulation of these important endogenous signaling 
molecules. In line with this, we recently found that mEH has 
a significant effect on blood perfusion in the mouse brain 
(Marowsky et al. 2016). However, this is best explained by 
the expression of mEH in the cerebral vascular endothelium 
(Marowsky et al. 2009) where it is ideally situated to process 
vasodilatory EETs.
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